Krystal Biotech (KRYS) PT Raised to $395 at Evercore ISI
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Price: $333.85 -0.84%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Evercore ISI analyst Josh Schimmer raised the price target on Krystal Biotech (NASDAQ: KRYS) to $395.00 (from $300.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy
- TransUnion (TRU) PT Lowered to $82 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
